Pharma Journalist - Page 33 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

Cencora to Invest $1 Billion in Expanding U.S. Pharmaceutical Distribution Network by 2030

Eli Lilly to Invest $3 Billion in New Manufacturing Facility in the Netherlands

UCB Secures FDA Approval for KYGEVVI, the First-Ever Treatment for Ultra-Rare TK2 Deficiency

IntoCell and Xcellon Biologics Partner to Advance Next-Generation ADC Development and Manufacturing

Helex Raises $3.5 Million Seed Round to Advance Gene Therapy for Genetic Kidney Diseases

FDA Grants Orphan Drug Designation to Dewpoint Therapeutics’ First-in-Class Gastric Cancer Drug

Eli Lilly to Invest $1.2 Billion in Puerto Rico Manufacturing Expansion

Novo Nordisk Makes $6.5 Billion Unsolicited Bid to Acquire Biotech Firm Metsera

Debiopharm and NetTargets Partner to Develop AI-Driven Dual-Payload Cancer Therapies

Seres Therapeutics Receives $3.6 Million CARB-X Grant to Develop Liquid Form of SER-155 for Infection Prevention